Advertisement

Conjunctivitis Preferred Practice Pattern®

Published:October 23, 2018DOI:https://doi.org/10.1016/j.ophtha.2018.10.020
      AMERICAN ACADEMY™ OF OPHTHALMOLOGY
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook.
        SIGN, Edinburgh2015 (SIGN publication no. 50). [November 2015].
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE Working Group
        Organizations that have endorsed or that are using GRADE.
        http://www.gradeworkinggroup.org/
        Date accessed: June 19, 2018
        • Smith AF
        • Waycaster C
        Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States.
        BMC Ophthalmol. 2009; 9: 13
        • Zegans ME
        • Sanchez PA
        • Likosky DS
        • et al.
        Clinical features, outcomes, and costs of a conjunctivitis outbreak caused by the ST448 strain of Streptococcus pneumoniae.
        Cornea. 2009; 28: 503-509
        • Rutala WA
        • Weber DJ
        • Healthcare Infection Control Practices Advisory Committee (HICPAC)
        Guideline for disinfection and sterilization in healthcare facilities.
        • Junk AK
        • Chen PP
        • Lin SC
        • et al.
        Disinfection of Tonometers: A Report by the American Academy of Ophthalmology.
        Ophthalmology. 2017; 124: 1867-1875
        • Epling J
        Bacterial conjunctivitis.
        BMJ Clin Evid. 2012; 2012
        • Cornea Society AAO
        Recommendations for Herpes Zoster Vaccine for Patients 50 Years of Age and Older.
        Ophthalmology. 2018; (In Press.)
        • McCulley JP
        • Dougherty JM
        • Deneau DG
        Classification of chronic blepharitis.
        Ophthalmology. 1982; 89: 1173-1180
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern®. Dry Eye Syndrome.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Chiang YP
        • Wang F
        • Javitt JC
        Office visits to ophthalmologists and other physicians for eye care among the U.S. population, 1990.
        Public Health Rep. 1995; 110: 147-153
        • Jalbert I
        • Golebiowski B
        Environmental aeroallergens and allergic rhino-conjunctivitis.
        Curr Opin Allergy Clin Immunol. 2015; 15: 476-481
        • Nkosi V
        • Wichmann J
        • Voyi K
        Mine dumps, wheeze, asthma, and rhinoconjunctivitis among adolescents in South Africa: any association?.
        Int J Environ Health Res. 2015; 25: 583-600
        • Al-Wahaibi A
        • Zeka A
        Health impacts from living near a major industrial park in Oman.
        BMC Public Health. 2015; 15: 524
        • Shirinde J
        • Wichmann J
        • Voyi K
        Allergic rhinitis, rhinoconjunctivitis and hayfever symptoms among children are associated with frequency of truck traffic near residences: a cross sectional study.
        Environ Health. 2015; 14: 84
        • Solis-Soto MT
        • Patino A
        • Nowak D
        • Radon K
        Association between environmental factors and current asthma, rhinoconjunctivitis and eczema symptoms in school-aged children from Oropeza Province–Bolivia: a cross-sectional study.
        Environ Health. 2013; 12: 95
        • Arita R
        Validity of noninvasive meibography systems: noncontact meibography equipped with a slit-lamp and a mobile pen-shaped meibograph.
        Cornea. 2013; 32: S65-70
        • Garcia-Posadas L
        • Contreras-Ruiz L
        • Soriano-Romani L
        • Dartt DA
        • Diebold Y
        Conjunctival goblet cell function: effect of contact lens wear and cytokines.
        Eye Contact Lens. 2016; 42: 83-90
        • Stagi S
        • Pucci N
        • di Grande L
        • et al.
        Increased prevalence of growth hormone deficiency in patients with vernal keratoconjuntivitis; an interesting new association.
        Hormones (Athens). 2014; 13: 382-388
        • Sacchetti M
        • Lambiase A
        • Moretti C
        • Mantelli F
        • Bonini S
        Sex hormones in allergic conjunctivitis: altered levels of circulating androgens and estrogens in children and adolescents with vernal keratoconjunctivitis.
        J Immunol Res. 2015; 2015945317
        • Leonardi A
        • Lazzarini D
        • Motterle L
        • et al.
        Vernal keratoconjunctivitis-like disease in adults.
        Am J Ophthalmol. 2013; 155: 796-803
        • Saboo US
        • Jain M
        • Reddy JC
        • Sangwan VS
        Demographic and clinical profile of vernal keratoconjunctivitis at a tertiary eye care center in India.
        Indian J Ophthalmol. 2013; 61: 486-489
        • Ibrahim OM
        • Matsumoto Y
        • Dogru M
        • et al.
        In vivo confocal microscopy evaluation of meibomian gland dysfunction in atopic-keratoconjunctivitis patients.
        Ophthalmology. 2012; 119: 1961-1968
        • Sy H
        • Bielory L
        Atopic keratoconjunctivitis.
        Allergy Asthma Proc. 2013; 34: 33-41
        • Rodriguez-Garcia A
        • Gonzalez-Godinez S
        • Lopez-Rubio S
        Blepharokeratoconjunctivitis in childhood: corneal involvement and visual outcome.
        Eye (Lond). 2016; 30: 438-446
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern®. Blepharitis.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Saidel MA
        • Paik JY
        • Garcia C
        • Russo P
        • Cao D
        • Bouchard C
        Prevalence of sleep apnea syndrome and high-risk characteristics among keratoconus patients.
        Cornea. 2012; 31: 600-603
        • Stern GA
        Focal Points 2012 Module: Chronic Conjunctivitis, Part 2.
        American Academy of Ophthalmology, San Francisco, CA2012: 3
        • Turaka K
        • Penne RB
        • Rapuano CJ
        • et al.
        Giant fornix syndrome: a case series.
        Ophthal Plast Reconstr Surg. 2012; 28: 4-6
        • Hahn JM
        • Meisler DM
        • Lowder CY
        • Tung RC
        • Camisa C
        Cicatrizing conjunctivitis associated with paraneoplastic lichen planus.
        Am J Ophthalmol. 2000; 129: 98-99
        • Ueta M
        Genetic predisposition to Stevens-Johnson syndrome with severe ocular surface complications.
        Cornea. 2015; 34: S158-165
        • Manrique Lipa RK
        • de los Bueis AB
        • De los Rios JJ
        • Manrique Lipa RD
        Sarcoidosis presenting as acute bulbar follicular conjunctivitis.
        Clin Exp Optom. 2010; 93: 363-365
        • Dithmar S
        • Waring 3rd, GO
        • Goldblum TA
        • Grossniklaus HE
        Conjunctival deposits as an initial manifestation of sarcoidosis.
        Am J Ophthalmol. 1999; 128: 361-362
        • Geggel HS
        • Mensher JH
        Cicatricial conjunctivitis in sarcoidosis: recognition and treatment.
        Ann Ophthalmol. 1989; 21: 92-94
        • Bullen CL
        • Liesegang TJ
        • McDonald TJ
        • DeRemee RA
        Ocular complications of Wegener's granulomatosis.
        Ophthalmology. 1983; 90: 279-290
        • Akova YA
        • Jabbur NS
        • Foster CS
        Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.
        Ophthalmology. 1993; 100: 1775-1781
        • Caster JC
        • Shetlar DJ
        • Pappolla MA
        • Yee RW
        Microscopic polyangiitis with ocular involvement.
        Arch Ophthalmol. 1996; 114: 346-348
        • Herbort CP
        • Rao NA
        • Mochizuki M
        • members of Scientific Committee of First International Workshop on Ocular S
        International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS).
        Ocul Immunol Inflamm. 2009; 17: 160-169
        • Miserocchi E
        • Modorati G
        • Di Matteo F
        • Galli L
        • Rama P
        • Bandello F
        Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors.
        Eur J Ophthalmol. 2011; 21: 802-810
        • Grau RG
        Drug-induced vasculitis: new insights and a changing lineup of suspects.
        Curr Rheumatol Rep. 2015; 17: 71
        • Birnbaum AD
        • Rifkin LM
        Sarcoidosis: sex-dependent variations in presentation and management.
        J Ophthalmol. 2014; 2014236905
        • Rao N
        • McLean J
        • Zimmerman L
        Sebaceous carcinoma of the eyelid and caruncle: correlation of clinicopathologic features with prognosis.
        in: Jakobiec F Ocular and Adnexal Tumors. Aesculapius, Birmingham1978
        • Akpek EK
        • Polcharoen W
        • Chan R
        • Foster CS
        Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis.
        Cornea. 1999; 18: 282-288
        • Tsatsos M
        • MacGregor C
        • Athanasiadis I
        • Moschos MM
        • Hossain P
        • Anderson D
        Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
        Clin Exp Ophthalmol. 2016; 44: 824-837
        • Souza PM
        • Holland EJ
        • Huang AJ
        Bilateral herpetic keratoconjunctivitis.
        Ophthalmology. 2003; 110: 493-496
        • Chiang WY
        • Liu TT
        • Huang WT
        • Kuo MT
        Co-existing ligneous conjunctivitis and IgG4-related disease.
        Indian J Ophthalmol. 2016; 64: 532-534
        • Chalmers DA
        Rosacea: recognition and management for the primary care provider.
        Nurse Pract. 1997; 22 (23-18, 30.): 18
        • Feder RS
        • Olsen TW
        • Prum Jr., BE
        • et al.
        Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern((R)) Guidelines.
        Ophthalmology. 2016; 123: P209-236
        • Rapoza PA
        • Quinn TC
        • Kiessling LA
        • Green WR
        • Taylor HR
        Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia.
        JAMA. 1986; 255: 3369-3373
        • Sambursky R
        • Tauber S
        • Schirra F
        • Kozich K
        • Davidson R
        • Cohen EJ
        The RPS adeno detector for diagnosing adenoviral conjunctivitis.
        Ophthalmology. 2006; 113: 1758-1764
        • Kam KY
        • Ong HS
        • Bunce C
        • Ogunbowale L
        • Verma S
        Sensitivity and specificity of the AdenoPlus point-of-care system in detecting adenovirus in conjunctivitis patients at an ophthalmic emergency department: a diagnostic accuracy study.
        Br J Ophthalmol. 2015; 99: 1186-1189
        • Udeh BL
        • Schneider JE
        • Ohsfeldt RL
        Cost effectiveness of a point-of-care test for adenoviral conjunctivitis.
        Am J Med Sci. 2008; 336: 254-264
        • Choi S
        • Moon SW
        • Shin JH
        • Park HK
        • Jin KH
        Label-free biochemical analytic method for the early detection of adenoviral conjunctivitis using human tear biofluids.
        Anal Chem. 2014; 86: 11093-11099
        • Dreyfuss JL
        • Regatieri CV
        • Coelho B
        • et al.
        Altered hyaluronic acid content in tear fluid of patients with adenoviral conjunctivitis.
        An Acad Bras Cienc. 2015; 87: 455-462
        • Johnson RE
        • Newhall WJ
        • Papp JR
        • et al.
        Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections–2002.
        MMWR Recomm Rep. 2002; 51: 1-38
        • Stenberg K
        • Herrmann B
        • Dannevig L
        • Elbagir AN
        • Mardh PA
        Culture, ELISA and immunofluorescence tests for the diagnosis of conjunctivitis caused by Chlamydia trachomatis in neonates and adults.
        Apmis. 1990; 98: 514-520
        • Kowalski RP
        • Uhrin M
        • Karenchak LM
        • Sweet RL
        • Gordon YJ
        Evaluation of the polymerase chain reaction test for detecting chlamydial DNA in adult chlamydial conjunctivitis.
        Ophthalmology. 1995; 102: 1016-1019
        • Kessler HH
        • Pierer K
        • Stuenzner D
        • Auer-Grumbach P
        • Haller EM
        • Marth E
        Rapid detection of Chlamydia trachomatis in conjunctival, pharyngeal, and urethral specimens with a new polymerase chain reaction assay.
        Sex Transm Dis. 1994; 21: 191-195
        • Kowalski RP
        • Karenchak LM
        • Raju LV
        • Ismail N
        The verification of nucleic acid amplification testing (Gen-Probe Aptima Assay) for chlamydia trachomatis from ocular samples.
        Ophthalmology. 2015; 122: 244-247
        • De Smedt S
        • Wildner G
        • Kestelyn P
        Vernal keratoconjunctivitis: an update.
        Br J Ophthalmol. 2013; 97: 9-14
        • Power WJ
        • Neves RA
        • Rodriguez A
        • Dutt JE
        • Foster CS
        Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid.
        Ophthalmology. 1995; 102: 1158-1163
        • Foster CS
        Cicatricial pemphigoid.
        Trans Am Ophthalmol Soc. 1986; 84: 527-663
        • Srikumaran D
        • Akpek EK
        Mucous membrane pemphigoid: recent advances.
        Curr Opin Ophthalmol. 2012; 23: 523-527
        • Radford CF
        • Rauz S
        • Williams GP
        • Saw VP
        • Dart JK
        Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United Kingdom.
        Eye (Lond). 2012; 26: 1199-1208
        • Gilberg S
        • Tse D
        Malignant eyelid tumors.
        Ophthalmol Clin North Am. 1992; 5: 261-285
        • Pasadhika S
        • Rosenbaum JT
        Ocular sarcoidosis.
        Clin Chest Med. 2015; 36: 669-683
        • Leonardi A
        • Piliego F
        • Castegnaro A
        • et al.
        Allergic conjunctivitis: a cross-sectional study.
        Clin Exp Allergy. 2015; 45: 1118-1125
        • Mimura T
        • Usui T
        • Yamagami S
        • Miyai T
        • Amano S
        Relation between total tear IgE and severity of acute seasonal allergic conjunctivitis.
        Curr Eye Res. 2012; 37: 864-870
        • Armentia A
        • Iglesias B
        • Iglesias D
        • et al.
        Component-resolved diagnostics in vernal conjunctivitis.
        Ann Allergy Asthma Immunol. 2015; 115: 446-450
        • Kruse K
        • Gerwin E
        • Eichel A
        • Shah-Hosseini K
        • Mosges R
        Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
        J Allergy Clin Immunol Pract. 2015; 3: 381-386
        • Cher I
        Clinical features of superior limbic keroconjunctivitis in Australia. A probable association with thyrotoxicosis.
        Arch Ophthalmol. 1969; 82: 580-586
        • Yenigun A
        • Dadaci Z
        • Oncel M
        Plasma vitamin D levels of patients with allergic rhino-conjunctivitis with positive skin prick test.
        Am J Rhinol Allergy. 2015; 29: e46-49
        • Dadaci Z
        • Borazan M
        • Kiyici A
        • Oncel Acir N
        Plasma vitamin D and serum total immunoglobulin E levels in patients with seasonal allergic conjunctivitis.
        Acta Ophthalmol. 2014; 92: e443-446
        • Lierl MB
        New developments in the treatment of pediatric allergic rhinitis and conjunctivitis.
        Pediatr Ann. 2014; 43: e192-200
        • Zicari AM
        • Cafarotti A
        • Occasi F
        • et al.
        Vitamin D levels in children affected by vernal keratoconjunctivitis.
        Curr Med Res Opin. 2017; 33: 269-274
        • Bozkurt B
        • Artac H
        • Ozdemir H
        • Unlu A
        • Bozkurt MK
        • Irkec M
        Serum vitamin D levels in children with vernal keratoconjunctivitis.
        Ocul Immunol Inflamm. 2016; : 1-5
        • Tenzel RR
        Comments on superior limbic filamentous keratitis: II.
        Arch Ophthalmol. 1968; 79: 508
        • Theodore FH
        Comments on findings of elevated protein-bound iodine in superior limbic keratoconjunctivitis: I.
        Arch Ophthalmol. 1968; 79: 508
        • Wang P
        • Yu DJ
        • Feng G
        • et al.
        Is Floppy Eyelid Syndrome More Prevalent in Obstructive Sleep Apnea Syndrome Patients?.
        J Ophthalmol. 2016; 20166980281
        • Carter SB
        • Cohen EJ
        Development of herpes simplex virus infectious epithelial keratitis during oral acyclovir therapy and response to topical antivirals.
        Cornea. 2016; 35: 692-695
        • Erekosima N
        • Suarez-Cuervo C
        • Ramanathan M
        • et al.
        Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.
        Laryngoscope. 2014; 124: 616-627
        • Bertelsen RJ
        • Brantsaeter AL
        • Magnus MC
        • et al.
        Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases.
        J Allergy Clin Immunol. 2014; 133: 165-171
        • Blaiss MS
        • Dykewicz MS
        • Skoner DP
        • et al.
        Diagnosis and treatment of nasal and ocular allergies: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys.
        Ann Allergy Asthma Immunol. 2014; 112: 322-328
        • Centers for Disease Control and Prevention
        Sexually transmitted diseases treatment guidelines, 2010.
        MMWR Morb Mortal Wkly Rep. 2010; 59: 55
        • Isenberg SJ
        • Apt L
        • Wood M
        A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum.
        N Engl J Med. 1995; 332: 562-566
        • Isenberg SJ
        • Apt L
        • Yoshimori R
        • Leake RD
        • Rich R
        Povidone-iodine for ophthalmia neonatorum prophylaxis.
        Am J Ophthalmol. 1994; 118: 701-706
        • David M
        • Rumelt S
        • Weintraub Z
        Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum.
        Ophthalmology. 2011; 118: 1454-1458
        • Dooling KL
        • Guo A
        • Patel M
        • et al.
        Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 103-108
        • Centers for Disease Control and Prevention
        Vaccines and Preventable Diseases. Measles, mumps, rubella (MMR) vaccination: what everyone should know.
        • Knopf HL
        • Hierholzer JC
        Clinical and immunologic responses in patients with viral keratoconjunctivitis.
        Am J Ophthalmol. 1975; 80: 661-672
        • Warren D
        • Nelson KE
        • Farrar JA
        • et al.
        A large outbreak of epidemic keratoconjunctivitis: problems in controlling nosocomial spread.
        J Infect Dis. 1989; 160: 938-943
        • Buehler JW
        • Finton RJ
        • Goodman RA
        • et al.
        Epidemic keratoconjunctivitis: report of an outbreak in an ophthalmology practice and recommendations for prevention.
        Infect Control. 1984; 5: 390-394
        • Reilly S
        • Dhillon BJ
        • Nkanza KM
        • et al.
        Adenovirus type 8 keratoconjunctivitis–an outbreak and its treatment with topical human fibroblast interferon.
        J Hyg (Lond). 1986; 96: 557-575
        • Koo D
        • Bouvier B
        • Wesley M
        • Courtright P
        • Reingold A
        Epidemic keratoconjunctivitis in a university medical center ophthalmology clinic; need for re-evaluation of the design and disinfection of instruments.
        Infect Control Hosp Epidemiol. 1989; 10: 547-552
        • Stern ME
        • Beuerman RW
        • Fox RI
        • Gao J
        • Mircheff AK
        • Pflugfelder SC
        The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
        Cornea. 1998; 17: 584-589
        • Rutala WA
        • Peacock JE
        • Gergen MF
        • Sobsey MD
        • Weber DJ
        Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities.
        Antimicrob Agents Chemother. 2006; 50: 1419-1424
        • Gordon YJ
        • Gordon RY
        • Romanowski E
        • Araullo-Cruz TP
        Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro.
        Ophthalmology. 1993; 100 (discussion 1839-1840.): 1835-1839
        • Nauheim RC
        • Romanowski EG
        • Araullo-Cruz T
        • et al.
        Prolonged recoverability of desiccated adenovirus type 19 from various surfaces.
        Ophthalmology. 1990; 97: 1450-1453
        • Haag-Streit Diagnostics
        Instructions for use. Cleaning and disinfection: tonometer measuring prisms, contact glasses, and Desinset.
        • Reichert Technologies
        CT100 contact tonometer user's guide.
        • Cillino S
        • Casuccio A
        • Giammanco GM
        • et al.
        Tonometers and infectious risk: myth or reality? Efficacy of different disinfection regimens on tonometer tips.
        Eye. 2007; 21: 541-546
        • Craven ER
        • Butler SL
        • McCulley JP
        • Luby JP
        Applanation tonometer tip sterilization for adenovirus type 8.
        Ophthalmology. 1987; 94: 1538-1540
        • Kuo IC
        • Espinosa C
        • Forman M
        • Valsamakis A
        A polymerase chain reaction-based algorithm to detect and prevent transmission of adenoviral conjunctivitis in hospital employees.
        Am J Ophthalmol. 2016; 163: 38-44
        • Owen CG
        • Shah A
        • Henshaw K
        • Smeeth L
        • Sheikh A
        Topical treatments for seasonal allergic conjunctivitis: systematic review and meta-analysis of efficacy and effectiveness.
        Br J Gen Pract. 2004; 54: 451-456
      1. In: Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness. Ottawa (ON)2016.

        • Castillo M
        • Scott NW
        • Mustafa MZ
        • Mustafa MS
        • Azuara-Blanco A
        Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis.
        Cochrane Database Syst Rev. 2015; CD009566
        • Kam KW
        • Chen LJ
        • Wat N
        • Young AL
        Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
        Ocul Immunol Inflamm. 2017; 25: 663-677
      2. New drugs for allergic conjunctivitis.
        Med Lett Drugs Ther. 2000; 42: 39-40
        • Abelson MB
        • Torkildsen GL
        • Williams JI
        • Gow JA
        • Gomes PJ
        • McNamara TR
        Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
        Clin Ther. 2009; 31: 1908-1921
        • Borazan M
        • Karalezli A
        • Akova YA
        • Akman A
        • Kiyici H
        • Erbek SS
        Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
        Acta Ophthalmol. 2009; 87: 549-554
        • Figus M
        • Fogagnolo P
        • Lazzeri S
        • et al.
        Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study.
        Eur J Ophthalmol. 2010; 20: 811-818
        • Fujishima H
        • Fukagawa K
        • Tanaka M
        • et al.
        The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.
        Ophthalmologica. 2008; 222: 232-239
        • Macejko TT
        • Bergmann MT
        • Williams JI
        • et al.
        Multicenter clinical evaluation of bepotastine besilate ophthalmic solutions 1.0% and 1.5% to treat allergic conjunctivitis.
        Am J Ophthalmol. 2010; 150: 122-127
        • Abelson MB
        • Shetty S
        • Korchak M
        • Butrus SI
        • Smith LM
        Advances in pharmacotherapy for allergic conjunctivitis.
        Expert Opin Pharmacother. 2015; 16: 1219-1231
        • Torkildsen GL
        • Williams JI
        • Gow JA
        • Gomes PJ
        • Abelson MB
        • McNamara TR
        Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge.
        Ann Allergy Asthma Immunol. 2010; 105: 57-64
        • La Rosa M
        • Lionetti E
        • Reibaldi M
        • et al.
        Allergic conjunctivitis: a comprehensive review of the literature.
        Ital J Pediatr. 2013; 39: 18
        • Welch D
        • Ousler 3rd, GW
        • Nally LA
        • Abelson MB
        • Wilcox KA
        Ocular drying associated with oral antihistamines (loratadine) in the normal population-an evaluation of exaggerated dose effect.
        Adv Exp Med Biol. 2002; 506: 1051-1055
        • Erdinest N
        • Solomon A
        Topical immunomodulators in the management of allergic eye diseases.
        Curr Opin Allergy Clin Immunol. 2014; 14: 457-463
        • Wei Q
        • Le Q
        • Hong J
        • Xiang J
        • Wei A
        • Xu J
        In vivo confocal microscopy of meibomian glands and palpebral conjunctiva in vernal keratoconjunctivitis.
        Indian J Ophthalmol. 2015; 63: 327-330
        • Wan KH
        • Chen LJ
        • Rong SS
        • Pang CP
        • Young AL
        Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.
        Ophthalmology. 2013; 120: 2197-2203
        • Lin SY
        • Erekosima N
        • Kim JM
        • et al.
        Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
        JAMA. 2013; 309: 1278-1288
        • Nelson H
        • Cartier S
        • Allen-Ramey F
        • Lawton S
        • Calderon MA
        Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
        J Allergy Clin Immunol Pract. 2015; 3 (e253.): 256-266
      3. Lin SY, Erekosima N, Suarez-Cuervo C, et al. In: Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review. Rockville (MD)2013.

        • Banerjee K
        • Mathie RT
        • Costelloe C
        • Howick J
        Homeopathy for allergic rhinitis: a systematic review.
        J Altern Complement Med. 2017; 23: 426-444
        • Di Bona D
        • Plaia A
        • Leto-Barone MS
        • La Piana S
        • Di Lorenzo G
        Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis.
        JAMA Intern Med. 2015; 175: 1301-1309
        • Calderon MA
        • Penagos M
        • Sheikh A
        • Canonica GW
        • Durham S
        Sublingual immunotherapy for treating allergic conjunctivitis.
        Cochrane Database Syst Rev. 2011; CD007685
        • Wu LQ
        • Chen X
        • Lou H
        • Cheng JW
        • Wei RL
        Loteprednol etabonate in the treatment of allergic conjunctivitis: a meta-analysis.
        Curr Med Res Opin. 2015; 31: 1509-1518
        • Sharma N
        • Rao K
        • Maharana PK
        • Vajpayee RB
        Ocular allergy and keratoconus.
        Indian J Ophthalmol. 2013; 61: 407-409
        • Shetty R
        • Sureka S
        • Kusumgar P
        • Sethu S
        • Sainani K
        Allergen-specific exposure associated with high immunoglobulin E and eye rubbing predisposes to progression of keratoconus.
        Indian J Ophthalmol. 2017; 65: 399-402
      4. Erratum: Allergen specific exposure associated with high immunoglobulin E and eye rubbing predisposes to progression of keratoconus.
        Indian J Ophthalmol. 2017; 65: 642-643
        • Naderan M
        • Rajabi MT
        • Zarrinbakhsh P
        • Bakhshi A
        Effect of allergic diseases on keratoconus severity.
        Ocul Immunol Inflamm. 2017; 25: 418-423
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern® Guidelines. Corneal Ectasia.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Mantelli F
        • Santos MS
        • Petitti T
        • et al.
        Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.
        Br J Ophthalmol. 2007; 91: 1656-1661
        • Pucci N
        • Novembre E
        • Cianferoni A
        • et al.
        Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
        Ann Allergy Asthma Immunol. 2002; 89: 298-303
        • Kiliç A
        • Gürler B
        Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
        Can J Ophthalmol. 2006; 41: 693-698
        • Ozcan AA
        • Ersoz TR
        • Dulger E
        Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
        Cornea. 2007; 26: 1035-1038
        • Akpek EK
        • Dart JK
        • Watson S
        • et al.
        A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
        Ophthalmology. 2004; 111: 476-482
        • Daniell M
        • Constantinou M
        • Vu HT
        • Taylor HR
        Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis.
        Br J Ophthalmol. 2006; 90: 461-464
        • Lambiase A
        • Leonardi A
        • Sacchetti M
        • Deligianni V
        • Sposato S
        • Bonini S
        Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study.
        J Allergy Clin Immunol. 2011; 128: 896-897
        • Oray M
        • Toker E
        Tear cytokine levels in vernal keratoconjunctivitis: the effect of topical 0.05% cyclosporine a therapy.
        Cornea. 2013; 32: 1149-1154
        • Gonzalez-Lopez JJ
        • Lopez-Alcalde J
        • Morcillo Laiz R
        • Fernandez Buenaga R
        • Rebolleda Fernandez G
        Topical cyclosporine for atopic keratoconjunctivitis.
        Cochrane Database Syst Rev. 2012; CD009078
        • Holsclaw DS
        • Whitcher JP
        • Wong IG
        • Margolis TP
        Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis.
        Am J Ophthalmol. 1996; 121: 243-249
        • Gane J
        • Buckley R
        Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis.
        J Allergy Clin Immunol Pract. 2013; 1: 65-74
        • Zanjani H
        • Aminifard MN
        • Ghafourian A
        • et al.
        Comparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: A randomized, double-masked study.
        Cornea. 2017; 36: 675-678
        • Chen JJ
        • Applebaum DS
        • Sun GS
        • Pflugfelder SC
        Atopic keratoconjunctivitis: A review.
        J Am Acad Dermatol. 2014; 70: 569-575
        • Kheirkhah A
        • Zavareh MK
        • Farzbod F
        • Mahbod M
        • Behrouz MJ
        Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis.
        Eye (Lond). 2011; 25: 872-880
        • Vichyanond P
        • Kosrirukvongs P
        Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
        Curr Allergy Asthma Rep. 2013; 13: 308-314
        • Li A
        • Li S
        • Ruan F
        • Jie Y
        Atopic keratoconjunctivitis: A diagnostic dilemma-a case report.
        Medicine (Baltimore). 2018; 97e0372
        • Rikkers SM
        • Holland GN
        • Drayton GE
        • Michel FK
        • Torres MF
        • Takahashi S
        Topical tacrolimus treatment of atopic eyelid disease.
        Am J Ophthalmol. 2003; 135: 297-302
        • Meurer M
        • Lubbe J
        • Kapp A
        • Schneider D
        The role of pimecrolimus cream 1% (Elidel) in managing adult atopic eczema.
        Dermatology. 2007; 215: 18-26
        • Eichenfield LF
        • Thaci D
        • de Prost Y
        • Puig L
        • Paul C
        Clinical management of atopic eczema with pimecrolimus cream 1% (Elidel) in paediatric patients.
        Dermatology. 2007; 215: 3-17
        • Muller EG
        • Santos MSD
        • Freitas D
        • Gomes JAP
        • Belfort Jr., R
        Tacrolimus eye drops as monotherapy for vernal keratoconjunctivitis: a randomized controlled trial.
        Arq Bras Oftalmol. 2017; 80: 154-158
        • Pucci N
        • Caputo R
        • di Grande L
        • et al.
        Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
        Pediatr Allergy Immunol. 2015; 26: 256-261
        • Ohashi Y
        • Ebihara N
        • Fujishima H
        • et al.
        A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis.
        J Ocul Pharmacol Ther. 2010; 26: 165-174
        • McNeill AM
        • Koo JY
        “Unknown Risks” of non-steroid topical medications for atopic dermatitis.
        Int J Dermatol. 2007; 46: 656-658
        • Ormerod AD
        Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?.
        Br J Dermatol. 2005; 153: 701-705
        • Bhat P
        • Birnbaum AD
        Focal Points 2015 Module: Diagnosis and Management of Noninfectious Corneal Ulceration and Melting.
        American Academy of Ophthalmology, San Francisco, CA2015
        • Arora R
        • Jain P
        • Gupta D
        • Goyal JL
        Sterile keratitis after corneal collagen crosslinking in a child.
        Cont Lens Anterior Eye. 2012; 35: 233-235
        • Perry HD
        • Doshi-Carnevale S
        • Donnenfeld ED
        • Kornstein HS
        Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
        Ophthalmology. 2003; 110: 1578-1581
        • Lemp MA
        • Nichols KK
        Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.
        Ocul Surf. 2009; 7: S1-S14
        • Albietz J
        • Sanfilippo P
        • Troutbeck R
        • Lenton LM
        Management of filamentary keratitis associated with aqueous-deficient dry eye.
        Optom Vis Sci. 2003; 80: 420-430
        • Sun YC
        • Hsiao CH
        • Chen WL
        • Wang IJ
        • Hou YC
        • Hu FR
        Conjunctival resection combined with tenon layer excision and the involvement of mast cells in superior limbic keratoconjunctivitis.
        Am J Ophthalmol. 2008; 145: 445-452
        • Kadrmas EF
        • Bartley GB
        Superior limbic keratoconjunctivitis. A prognostic sign for severe Graves ophthalmopathy.
        Ophthalmology. 1995; 102: 1472-1475
        • Jeng BH
        • Halfpenny CP
        • Meisler DM
        • Stock EL
        Management of focal limbal stem cell deficiency associated with soft contact lens wear.
        Cornea. 2011; 30: 18-23
        • Kim BY
        • Riaz KM
        • Bakhtiari P
        • et al.
        Medically reversible limbal stem cell disease: clinical features and management strategies.
        Ophthalmology. 2014; 121: 2053-2058
        • Rossen J
        • Amram A
        • Milani B
        • et al.
        Contact Lens-induced Limbal Stem Cell Deficiency.
        Ocul Surf. 2016; 14: 419-434
        • Khurana S
        • Sharma N
        • Agarwal T
        • et al.
        Comparison of olopatadine and fluorometholone in contact lens-induced papillary conjunctivitis.
        Eye Contact Lens. 2010; 36: 210-214
        • Diao H
        • She Z
        • Cao D
        • Wang Z
        • Lin Z
        Comparison of tacrolimus, fluorometholone, and saline in mild-to-moderate contact lens-induced papillary conjunctivitis.
        Adv Ther. 2012; 29: 645-653
        • Schwartz LK
        • Gelender H
        • Forster RK
        Chronic conjunctivitis associated with ‘floppy eyelids’.
        Arch Ophthalmol. 1983; 101: 1884-1888
        • Culbertson WW
        • Tseng SC
        Corneal disorders in floppy eyelid syndrome.
        Cornea. 1994; 13: 33-42
        • Compton CJ
        • Melson AT
        • Clark JD
        • Shipchandler TZ
        • Nunery WR
        • Lee HB
        Combined medial canthopexy and lateral tarsal strip for floppy eyelid syndrome.
        Am J Otolaryngol. 2016; 37: 240-244
        • Dutton JJ
        Surgical management of floppy eyelid syndrome.
        Am J Ophthalmol. 1985; 99: 557-560
        • Moore MB
        • Harrington J
        • McCulley JP
        Floppy eyelid syndrome. Management including surgery.
        Ophthalmology. 1986; 93: 184-188
        • Periman LM
        • Sires BS
        Floppy eyelid syndrome: a modified surgical technique.
        Ophthal Plast Reconstr Surg. 2002; 18: 370-372
        • Valenzuela AA
        • Sullivan TJ
        Medial upper eyelid shortening to correct medial eyelid laxity in floppy eyelid syndrome: a new surgical approach.
        Ophthal Plast Reconstr Surg. 2005; 21: 259-263
        • Karger RA
        • White WA
        • Park WC
        • et al.
        Prevalence of floppy eyelid syndrome in obstructive sleep apnea-hypopnea syndrome.
        Ophthalmology. 2006; 113: 1669-1674
        • Leibovitch I
        • Selva D
        Floppy eyelid syndrome: clinical features and the association with obstructive sleep apnea.
        Sleep Med. 2006; 7: 117-122
        • Ezra DG
        • Beaconsfield M
        • Sira M
        • Bunce C
        • Wormald R
        • Collin R
        The associations of floppy eyelid syndrome: a case control study.
        Ophthalmology. 2010; 117: 831-838
        • Chambe J
        • Laib S
        • Hubbard J
        • et al.
        Floppy eyelid syndrome is associated with obstructive sleep apnoea: a prospective study on 127 patients.
        J Sleep Res. 2012; 21: 308-315
        • Turaka K
        • Penne RB
        • Rapuano CJ
        • et al.
        Giant fornix syndrome: a case series.
        Ophthalmic Plast Reconstr Surg. 2012; 28: 4-6
        • Goldich Y
        • Ziai S
        • Artornsombudh P
        • et al.
        Characteristics of patients with ocular cicatricial pemphigoid referred to major tertiary hospital.
        Can J Ophthalmol. 2015; 50: 137-142
        • Holland EJ
        • Mannis MJ
        • Lee WB
        Ocular Surface Disease: Cornea, Conjunctiva and Tear Film: Expert Consult.
        1st ed. Saunders, Philadelphia, PA2013
        • Ellwein LB
        • Urato CJ
        Use of eye care and associated charges among the Medicare population: 1991-1998.
        Arch Ophthalmol. 2002; 120: 804-811
        • Saw VP
        • Dart JK
        • Rauz S
        • et al.
        Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
        Ophthalmology. 2008; 115: 253-261
        • Brunner M
        • Lacoste KJ
        • Bernauer W
        Control of ocular disease in mucous membrane pemphigoid.
        Klin Monbl Augenheilkd. 2014; 231: 331-334
        • Wilkins MR
        • Dart JK
        Mycophenolate mofetil for the treatment of severe inflammatory external eye diseases.
        Br J Ophthalmol. 2008; 92: 578-579
        • Nottage JM
        • Hammersmith KM
        • Murchison AP
        • Felipe AF
        • Penne R
        • Raber I
        Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
        Cornea. 2013; 32: 810-815
        • U.S. Food and Drug Administration Center for Drug Evaluation and Research
        Allergan, Inc. ACZONE™ (dapsone) Gel, 5%. NDA 021794-S006. 2008:2.
        • Nguyen QD
        • Foster CS
        Cicatricial pemphigoid: diagnosis and treatment.
        Int Ophthalmol Clin. 1996; 36: 41-60
        • Dragan L
        • Eng AM
        • Lam S
        • Persson T
        Tetracycline and niacinamide: treatment alternatives in ocular cicatricial pemphigoid.
        Cutis. 1999; 63: 181-183
        • Doan S
        • Lerouic JF
        • Robin H
        • Prost C
        • Savoldelli M
        • Hoang-Xuan T
        Treatment of ocular cicatricial pemphigoid with sulfasalazine.
        Ophthalmology. 2001; 108: 1565-1568
        • Doycheva D
        • Deuter C
        • Blumenstock G
        • Stuebiger N
        • Zierhut M
        Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.
        Ocul Immunol Inflamm. 2011; 19: 431-438
        • Foster CS
        • Ahmed AR
        Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
        Ophthalmology. 1999; 106: 2136-2143
        • Foster CS
        • Chang PY
        • Ahmed AR
        Combination of rituximab and intravenous immunoglobulin for recalcitrant ocular cicatricial pemphigoid: a preliminary report.
        Ophthalmology. 2010; 117: 861-869
        • Miserocchi E
        • Baltatzis S
        • Roque MR
        • Ahmed AR
        • Foster CS
        The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
        Ophthalmology. 2002; 109: 111-118
        • Chan LS
        • Ahmed AR
        • Anhalt GJ
        • et al.
        The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.
        Arch Dermatol. 2002; 138: 370-379
        • Yaghouti F
        • Nouri M
        • Abad JC
        • Power WJ
        • Doane MG
        • Dohlman CH
        Keratoprosthesis: preoperative prognostic categories.
        Cornea. 2001; 20: 19-23
        • Palioura S
        • Kim B
        • Dohlman CH
        • Chodosh J
        The Boston keratoprosthesis type I in mucous membrane pemphigoid.
        Cornea. 2013; 32: 956-961
        • Hart JW
        • Shiue LH
        • Shpall EJ
        • Alousi AM
        Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion.
        Ther Adv Hematol. 2013; 4: 320-334
        • Robinson MR
        • Lee SS
        • Rubin BI
        • et al.
        Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
        Bone Marrow Transplant. 2004; 33: 1031-1035
        • Lelli Jr., GJ
        • Musch DC
        • Gupta A
        • Farjo QA
        • Nairus TM
        • Mian SI
        Ophthalmic cyclosporine use in ocular GVHD.
        Cornea. 2006; 25: 635-638
        • Rao SN
        • Rao RD
        Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
        Cornea. 2006; 25: 674-678
        • Rocha EM
        • Pelegrino FS
        • de Paiva CS
        • Vigorito AC
        • de Souza CA
        GVHD dry eyes treated with autologous serum tears.
        Bone Marrow Transplant. 2000; 25: 1101-1103
        • Shikari H
        • Antin JH
        • Dana R
        Ocular graft-versus-host disease: a review.
        Surv Ophthalmol. 2013; 58: 233-251
        • Magro L
        • Gauthier J
        • Richet M
        • et al.
        Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC.
        Bone Marrow Transplant. 2017; 52: 878-882
        • Inamoto Y
        • Sun YC
        • Flowers ME
        • et al.
        Bandage soft contact lenses for ocular graft-versus-host disease.
        Biol Blood Marrow Transplant. 2015; 21: 2002-2007
        • Gregory DG
        New grading system and treatment guidelines for the acute ocular manifestations of Stevens-Johnson syndrome.
        Ophthalmology. 2016; 123: 1653-1658
        • Kohanim S
        • Palioura S
        • Saeed HN
        • et al.
        Stevens-Johnson syndrome/toxic epidermal necrolysis–a comprehensive review and guide to therapy. I. systemic disease.
        Ocul Surf. 2016; 14: 2-19
        • Kohanim S
        • Palioura S
        • Saeed HN
        • et al.
        Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis - a comprehensive review and guide to therapy. II. ophthalmic disease.
        Ocul Surf. 2016; 14: 168-188
        • Jain R
        • Sharma N
        • Basu S
        • et al.
        Stevens-Johnson syndrome: The role of an ophthalmologist.
        Surv Ophthalmol. 2016; 61: 369-399
        • Sharma N
        • Thenarasun SA
        • Kaur M
        • et al.
        Adjuvant role of amniotic membrane transplantation in acute ocular Stevens-Johnson syndrome: a randomized control trial.
        Ophthalmology. 2016; 123: 484-491
        • Hsu M
        • Jayaram A
        • Verner R
        • Lin A
        • Bouchard C
        Indications and outcomes of amniotic membrane transplantation in the management of acute stevens-johnson syndrome and toxic epidermal necrolysis: a case-control study.
        Cornea. 2012; 31: 1394-1402
        • Knackstedt T
        • Samie FH
        Sebaceous carcinoma: a review of the scientific literature.
        Curr Treat Options Oncol. 2017; 18: 47
        • Peksayar G
        • Altan-Yaycioglu R
        • Onal S
        Excision and cryosurgery in the treatment of conjunctival malignant epithelial tumours.
        Eye (Lond). 2003; 17: 228-232
        • Galor A
        • Karp CL
        • Chhabra S
        • Barnes S
        • Alfonso EC
        Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
        Br J Ophthalmol. 2010; 94: 551-554
        • Dawson CR
        • Hanna L
        • Wood TR
        • Despain R
        Adenovirus type 8 keratoconjunctivitis in the United States. 3. Epidemiologic, clinical, and microbiologic features.
        Am J Ophthalmol. 1970; 69: 473-480
        • Ford E
        • Nelson KE
        • Warren D
        Epidemiology of epidemic keratoconjunctivitis.
        Epidemiol Rev. 1987; 9: 244-261
        • Romanowski EG
        • Yates KA
        • Gordon YJ
        Topical corticosteroids of limited potency promote adenovirus replication in the Ad5/NZW rabbit ocular model.
        Cornea. 2002; 21: 289-291
        • Clement C
        • Capriotti JA
        • Kumar M
        • et al.
        Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis.
        Invest Ophthalmol Vis Sci. 2011; 52: 339-344
        • Melton R
        • Thomas R
        Stop EKC with a ‘silver bullet’.
        Rev Optom. 2008; 145
        • Pelletier JS
        • Stewart K
        • Trattler W
        • et al.
        A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis.
        Adv Ther. 2009; 26: 776-783
        • Pinto RD
        • Lira RP
        • Abe RY
        • et al.
        Dexamethasone/povidone eye drops versus artificial tears for treatment of presumed viral conjunctivitis: a randomized clinical trial.
        Curr Eye Res. 2015; 40: 870-877
        • Pepose JS
        • Ahuja A
        • Liu W
        • Narvekar A
        • Haque R
        Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis.
        Am J Ophthalmol. 2018;
        • Tabbara KF
        • Jarade EF
        Ganciclovir effects in adenoviral keratoconjunctivitis [abstract 3111-B253].
        ARVO. 2001; 42: S579
        • Campos M
        • Takahashi R
        • Tanaka H
        • Chamon W
        • Allemann N
        Inflammation-related scarring after photorefractive keratectomy.
        Cornea. 1998; 17: 607-610
        • Croxtall JD
        Ganciclovir ophthalmic gel 0.15%: in acute herpetic keratitis (dendritic ulcers).
        Drugs. 2011; 71: 603-610
        • Wilhelmus KR
        Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.
        Cochrane Database Syst Rev. 2015; 1CD002898
        • White ML
        • Chodosh J
        Herpes simplex virus keratitis: a treatment guideline.
        • Colin J
        • Prisant O
        • Cochener B
        • Lescale O
        • Rolland B
        • Hoang-Xuan T
        Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
        Ophthalmology. 2000; 107: 1507-1511
        • Tyring SK
        Efficacy of famciclovir in the treatment of herpes zoster.
        Semin Dermatol. 1996; 15: 27-31
        • Kaufman HE
        • Haw WH
        Ganciclovir ophthalmic gel 0.15%: safety and efficacy of a new treatment for herpes simplex keratitis.
        Curr Eye Res. 2012; 37: 654-660
        • Rudnick CM
        • Hoekzema GS
        Neonatal herpes simplex virus infections.
        Am Fam Physician. 2002; 65: 1138-1142
        • Matoba A
        Ocular viral infections.
        Pediatr Infect Dis. 1984; 3: 358-368
        • Li JY
        Herpes zoster ophthalmicus: acute keratitis.
        Curr Opin Ophthalmol. 2018; 29: 328-333
        • Ritterband DC
        • Friedberg DN
        Virus infections of the eye.
        Rev Med Virol. 1998; 8: 187-201
        • Szeto SK
        • Chan TC
        • Wong RL
        • Ng AL
        • Li EY
        • Jhanji V
        Prevalence of ocular manifestations and visual outcomes in patients with herpes zoster ophthalmicus.
        Cornea. 2017; 36: 338-342
        • Kaufman HE
        Treatment of viral diseases of the cornea and external eye.
        Prog Retin Eye Res. 2000; 19: 69-85
        • Charteris DG
        • Bonshek RE
        • Tullo AB
        Ophthalmic molluscum contagiosum: clinical and immunopathological features.
        Br J Ophthalmol. 1995; 79: 476-481
        • Sheikh A
        • Hurwitz B
        • van Schayck CP
        • McLean S
        • Nurmatov U
        Antibiotics versus placebo for acute bacterial conjunctivitis.
        Cochrane Database Syst Rev. 2012; CD001211
        • Ohnsman CM
        Exclusion of students with conjunctivitis from school: policies of state departments of health.
        J Pediatr Ophthalmol Strabismus. 2007; 44: 101-105
        • Isenberg SJ
        • Apt L
        • Valenton M
        • et al.
        A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
        Am J Ophthalmol. 2002; 134: 681-688
        • Isenberg SJ
        • Apt L
        • Valenton M
        • et al.
        Prospective, Randomized Clinical Trial of Povidone-Iodine 1.25% Solution Versus Topical Antibiotics for Treatment of Bacterial Keratitis.
        Am J Ophthalmol. 2017; 176: 244-253
        • Freidlin J
        • Acharya N
        • Lietman TM
        • Cevallos V
        • Whitcher JP
        • Margolis TP
        Spectrum of eye disease caused by methicillin-resistant Staphylococcus aureus.
        Am J Ophthalmol. 2007; 144: 313-315
        • Cavuoto K
        • Zutshi D
        • Karp CL
        • Miller D
        • Feuer W
        Update on bacterial conjunctivitis in South Florida.
        Ophthalmology. 2008; 115: 51-56
        • Klevens RM
        • Morrison MA
        • Nadle J
        • et al.
        Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
        JAMA. 2007; 298: 1763-1771
        • Avdic E
        • Cosgrove SE
        Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus.
        Expert Opin Pharmacother. 2008; 9: 1463-1479
        • Marangon FB
        • Miller D
        • Muallem MS
        • Romano AC
        • Alfonso EC
        Ciprofloxacin and levofloxacin resistance among methicillin-sensitive Staphylococcus aureus isolates from keratitis and conjunctivitis.
        Am J Ophthalmol. 2004; 137: 453-458
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern® Guidelines. Bacterial Keratitis.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Chen CJ
        • Starr CE
        Epidemiology of gram-negative conjunctivitis in neonatal intensive care unit patients.
        Am J Ophthalmol. 2008; 145: 966-970
        • Block SL
        Etiologic and therapeutic pitfalls of newborn conjunctivitis.
        Pediatr Ann. 2012; 41: 310-313
        • Jabs DA
        • Rosenbaum JT
        • Foster CS
        • et al.
        Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.
        Am J Ophthalmol. 2000; 130: 492-513
        • Suhler EB
        • Smith JR
        • Wertheim MS
        • et al.
        A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.
        Arch Ophthalmol. 2005; 123: 903-912
        • Jayne DR
        • Lockwood CM
        Pooled intravenous immunoglobulin in the management of systemic vasculitis.
        Adv Exp Med Biol. 1993; 336: 469-472
        • Kraft J
        • Lieb W
        • Zeitler P
        • Schuster V
        Ligneous conjunctivitis in a girl with severe type I plasminogen deficiency.
        Graefes Arch Clin Exp Ophthalmol. 2000; 238: 797-800
        • Watts P
        • Suresh P
        • Mezer E
        • et al.
        Effective treatment of ligneous conjunctivitis with topical plasminogen.
        Am J Ophthalmol. 2002; 133: 451-455
        • Kuonen A
        • Vaudaux J
        • Hamedani M
        • et al.
        Ligneous conjunctivitis in a young patient with homozygous K19E plasminogen gene mutation: a diagnostic and therapeutic challenge.
        Klin Monbl Augenheilkd. 2013; 230: 346-348
        • Leonardi A
        • Castegnaro A
        • Valerio AL
        • Lazzarini D
        Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study.
        Curr Opin Allergy Clin Immunol. 2015; 15: 482-488
        • Azari AA
        • Barney NP
        Conjunctivitis: a systematic review of diagnosis and treatment.
        JAMA. 2013; 310: 1721-1729
        • Petersen KD
        • Kronborg C
        • Gyrd-Hansen D
        • Dahl R
        • Larsen JN
        • Lowenstein H
        Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.
        Allergy. 2008; 63: 284-291
        • Virchow JC
        • Kay S
        • Demoly P
        • Mullol J
        • Canonica W
        • Higgins V
        Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients–an observational, cross sectional study in four countries in Europe.
        J Med Econ. 2011; 14: 305-314
        • Palmares J
        • Delgado L
        • Cidade M
        • Quadrado MJ
        • Filipe HP
        Allergic conjunctivitis: a national cross-sectional study of clinical characteristics and quality of life.
        Eur J Ophthalmol. 2010; 20: 257-264
        • Smith AF
        • Pitt AD
        • Rodruiguez AE
        • et al.
        The economic and quality of life impact of seasonal allergic conjunctivitis in a Spanish setting.
        Ophthalmic Epidemiol. 2005; 12: 233-242
        • Civelek E
        • Yavuz ST
        • Boz AB
        • et al.
        Epidemiology and burden of rhinitis and rhinoconjunctivitis in 9-to 11-year-old children.
        Am J Rhinol Allergy. 2010; 24: 364-370
        • Blaiss MS
        Allergic rhinoconjunctivitis: burden of disease.
        Allergy Asthma Proc. 2007; 28: 393-397
        • Bielory L
        • Skoner DP
        • Blaiss MS
        • et al.
        Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys.
        Allergy Asthma Proc. 2014; 35: 211-218
        • Uphoff E
        • Cabieses B
        • Pinart M
        • Valdes M
        • Anto JM
        • Wright J
        A systematic review of socioeconomic position in relation to asthma and allergic diseases.
        Eur Respir J. 2015; 46: 364-374
        • Chen YH
        • Lin CL
        • Bau DT
        • Hung YC
        Risk of allergic conjunctivitis in patients with type 1 diabetes mellitus: a population-based retrospective cohort study.
        BMJ Open. 2017; 7e015795
        • Bielory L
        • Syed BA
        Pharmacoeconomics of anterior ocular inflammatory disease.
        Curr Opin Allergy Clin Immunol. 2013; 13: 537-542
        • Pitt AD
        • Smith AF
        • Lindsell L
        • Voon LW
        • Rose PW
        • Bron AJ
        Economic and quality-of-life impact of seasonal allergic conjunctivitis in Oxfordshire.
        Ophthalmic Epidemiol. 2004; 11: 17-33
        • De Smedt S
        • Nkurikiye J
        • Fonteyne Y
        • et al.
        Vernal keratoconjunctivitis in school children in Rwanda and its association with socio-economic status: a population-based survey.
        Am J Trop Med Hyg. 2011; 85: 711-717
        • De Smedt SK
        • Nkurikiye J
        • Fonteyne YS
        • Tuft SJ
        • Gilbert CE
        • Kestelyn P
        Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care.
        Ophthalmology. 2012; 119: 1766-1772
        • Shekhawat NS
        • Shtein RM
        • Blachley TS
        • Stein JD
        Antibiotic prescription fills for acute conjunctivitis among enrollees in a large United States managed care network.
        Ophthalmology. 2017; 124: 1099-1107
        • Piednoir E
        • Bureau-Chalot F
        • Merle C
        • Gotzamanis A
        • Wuibout J
        • Bajolet O
        Direct costs associated with a nosocomial outbreak of adenoviral conjunctivitis infection in a long-term care institution.
        Am J Infect Control. 2002; 30: 407-410
        • Nanji AA
        • Moon CS
        • Galor A
        • Sein J
        • Oellers P
        • Karp CL
        Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
        Ophthalmology. 2014; 121: 994-1000
        • Sturges A
        • Butt AL
        • Lai JE
        • Chodosh J
        Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia.
        Ophthalmology. 2008; 115 (1302 e1291.): 1297-1302
        • Moon CS
        • Nanji AA
        • Galor A
        • McCollister KE
        • Karp CL
        Surgical versus medical treatment of ocular surface squamous neoplasia: a cost comparison.
        Ophthalmology. 2016; 123: 497-504
        • Feenstra RP
        • Tseng SC
        Comparison of fluorescein and rose bengal staining.
        Ophthalmology. 1992; 99: 605-617
        • Stroop WG
        • Chen TM
        • Chodosh J
        • et al.
        PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.
        Invest Ophthalmol Vis Sci. 2000; 41: 2096-2102
        • Manning FJ
        • Wehrly SR
        • Foulks GN
        Patient tolerance and ocular surface staining characteristics of lissamine green versus rose bengal.
        Ophthalmology. 1995; 102: 1953-1957